78 related articles for article (PubMed ID: 26431176)
41. The microenvironment in breast cancer progression: biology and implications for treatment.
Place AE; Jin Huh S; Polyak K
Breast Cancer Res; 2011; 13(6):227. PubMed ID: 22078026
[TBL] [Abstract][Full Text] [Related]
42. Regulation of breast cancer-induced bone lesions by β-catenin protein signaling.
Chen Y; Shi HY; Stock SR; Stern PH; Zhang M
J Biol Chem; 2011 Dec; 286(49):42575-42584. PubMed ID: 22009747
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity in breast cancer.
Polyak K
J Clin Invest; 2011 Oct; 121(10):3786-8. PubMed ID: 21965334
[TBL] [Abstract][Full Text] [Related]
44. Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer.
Jeong YJ; Bong JG; Park SH; Choi JH; Oh HK
J Breast Cancer; 2011 Jun; 14(2):96-103. PubMed ID: 21847403
[TBL] [Abstract][Full Text] [Related]
45. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland.
Subbaramaiah K; Howe LR; Bhardwaj P; Du B; Gravaghi C; Yantiss RK; Zhou XK; Blaho VA; Hla T; Yang P; Kopelovich L; Hudis CA; Dannenberg AJ
Cancer Prev Res (Phila); 2011 Mar; 4(3):329-46. PubMed ID: 21372033
[TBL] [Abstract][Full Text] [Related]
46. Molecular mechanisms of leptin and adiponectin in breast cancer.
Jardé T; Perrier S; Vasson MP; Caldefie-Chézet F
Eur J Cancer; 2011 Jan; 47(1):33-43. PubMed ID: 20889333
[TBL] [Abstract][Full Text] [Related]
47. F2-isoprostanes and Metabolite, and Breast Cancer Risk.
Dai Q; Zhu X
N Am J Med Sci (Boston); 2009 Jul; 2(3):106-108. PubMed ID: 20648235
[No Abstract] [Full Text] [Related]
48. Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications.
Macciò A; Madeddu C; Gramignano G; Mulas C; Floris C; Massa D; Astara G; Chessa P; Mantovani G
J Mol Med (Berl); 2010 Jul; 88(7):677-86. PubMed ID: 20339829
[TBL] [Abstract][Full Text] [Related]
49. Obesity and breast cancer: progress to understanding the relationship.
Brown KA; Simpson ER
Cancer Res; 2010 Jan; 70(1):4-7. PubMed ID: 20028864
[TBL] [Abstract][Full Text] [Related]
50. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
51. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study.
Dai Q; Gao YT; Shu XO; Yang G; Milne G; Cai Q; Wen W; Rothman N; Cai H; Li H; Xiang Y; Chow WH; Zheng W
J Clin Oncol; 2009 May; 27(15):2482-8. PubMed ID: 19380446
[TBL] [Abstract][Full Text] [Related]
52. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients.
Wiesner FG; Magener A; Fasching PA; Wesse J; Bani MR; Rauh C; Jud S; Schrauder M; Loehberg CR; Beckmann MW; Hartmann A; Lux MP
Breast; 2009 Apr; 18(2):135-41. PubMed ID: 19342238
[TBL] [Abstract][Full Text] [Related]
53. Adiponectin and leptin expression in primary ductal breast cancer and in adjacent healthy epithelial and myoepithelial tissue.
Jardé T; Caldefie-Chézet F; Damez M; Mishellany F; Perrone D; Penault-Llorca F; Guillot J; Vasson MP
Histopathology; 2008 Oct; 53(4):484-7. PubMed ID: 18983614
[No Abstract] [Full Text] [Related]
54. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.
Fiorio E; Mercanti A; Terrasi M; Micciolo R; Remo A; Auriemma A; Molino A; Parolin V; Di Stefano B; Bonetti F; Giordano A; Cetto GL; Surmacz E
BMC Cancer; 2008 Oct; 8():305. PubMed ID: 18945363
[TBL] [Abstract][Full Text] [Related]
55. Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma.
Jardé T; Caldefie-Chézet F; Damez M; Mishellany F; Penault-Llorca F; Guillot J; Vasson MP
Oncol Rep; 2008 Apr; 19(4):905-11. PubMed ID: 18357374
[TBL] [Abstract][Full Text] [Related]
56. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.
Howe LR
Breast Cancer Res; 2007; 9(4):210. PubMed ID: 17640394
[TBL] [Abstract][Full Text] [Related]
57. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
Vona-Davis L; Rose DP
Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
[TBL] [Abstract][Full Text] [Related]
58. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
[TBL] [Abstract][Full Text] [Related]
59. Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation.
Basu S
Med Res Rev; 2007 Jul; 27(4):435-68. PubMed ID: 17191216
[TBL] [Abstract][Full Text] [Related]
60. Additive effects of Cox-1 and Cox-2 inhibition on breast cancer in vitro.
McFadden DW; Riggs DR; Jackson BJ; Cunningham C
Int J Oncol; 2006 Oct; 29(4):1019-23. PubMed ID: 16964399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
